OpenVSafe by OpenVAERS
Search V-safe

E7W-21005-54493

5 vaccinations 10 coded responses 53 check-ins 10 free-text entries 5 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
020 / MA
Registered
2020-12-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-31
    Registered in v-safe
  2. 2020-12-31
    Dose 1 — Moderna
  3. 2020-12-31
    Survey response — day 0, dose 1
    MedDRA: No adverse event — Feeling: Fair · Headache, Joint pains, Fatigue or tiredness
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Lightheaded
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-01
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling, Itching · None
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Redness · None
    Adult check-in
  8. 2021-01-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Migraine, Pre-existing disease — Feeling: Poor · Be unable to work
    Free text: Migraine, consistent with known prior history and very unlikely to be related to the vaccine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-04
  10. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  12. 2021-01-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  13. 2021-01-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-01-21
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  15. 2021-01-29
    Dose 2 — Moderna
  16. 2021-01-29
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  19. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body aches
    Adult check-in
  20. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  21. 2021-02-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain — Feeling: Good
    Free text: Axillary pain, mild
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  23. 2021-02-05
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  24. 2021-02-12
    Survey response — day 14, dose 2
    MedDRA: Axillary pain, Lymphadenopathy — Feeling: Good
    Free text: Axillary pain and swelling, now improving
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-02-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-02-26
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-03-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-03-13
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-04-30
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-07-30
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-10-28
    Dose 3 — Moderna
  32. 2021-10-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness
    Adult check-in
  33. 2021-10-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Chills, Fatigue or tiredness
    Adult check-in
  35. 2021-11-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  36. 2021-11-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2021-11-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  38. 2021-11-04
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  39. 2021-11-11
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-11-18
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-11-25
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  42. 2021-12-02
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  43. 2021-12-09
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  44. 2022-01-27
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-05-01
    Survey response — 6 months, dose 3
    MedDRA: Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Covid symptoms-see below
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-05-01
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  47. 2022-05-03
    Call successful
    Participant prefers to complete VAERS report online
  48. 2022-05-12
    Dose 4 — Pfizer-BioNTech
  49. 2022-05-19
    Survey response — day 7, dose 4
    MedDRA: Heavy menstrual bleeding — Feeling: Good
    Free text: Very heavy menses
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-05-28
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-06-04
    Survey response — day 21, dose 4
    MedDRA: Endometrial hyperplasia, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Endometrial intraepithelial neoplasm · Healthcare visit (other): Will have surgery
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-06-04
    Report sent to call center — day 21, dose 4
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  53. 2022-06-07
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  54. 2022-06-09
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-06-18
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-06-25
    Survey response — day 42, dose 4
    MedDRA: Endometrial cancer stage 0, Surgery, Tumour excision — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Symptoms: Surgery for precancerous/early cancer endometrium · Healthcare visit (other): Surgery 6/24
    MedDRA releases: 2024-11 · check-in free text available
  57. 2022-06-25
    Report sent to call center — day 42, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  58. 2022-06-27
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  59. 2022-09-15
    Dose 5 — Moderna
  60. 2022-09-23
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  61. 2022-10-01
    Survey response — day 14, dose 5
    MedDRA: Body temperature increased, Exposure to SARS-CoV-2, Fatigue, SARS-CoV-2 test negative — Feeling: Good
    Free text: Low grade temp and severe fatigue 2 days with negative Covid test x2, now resolved; did begin 3 days after an exposure
    MedDRA releases: 2024-11 · check-in free text available
  62. 2022-10-06
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  63. 2022-10-18
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  64. 2022-10-20
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  65. 2022-10-27
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  66. 2022-12-15
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  67. 2023-03-16
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-31Moderna
22021-01-29Moderna
32021-10-28Moderna No
42022-05-12Pfizer-BioNTech No
52022-09-15Moderna No

Call center

5 call center cases

3 successful · 2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-31

Systemic reaction (other): No

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): Lightheaded

2021-01-04

Systemic reaction (other): Migraine, consistent with known prior history and very unlikely to be related to the vaccine

Release 3 — days 1–6 daily, dose 2

2021-02-03

Systemic reaction (other): Axillary pain, mild

Release 4 — day 14, dose 2

2021-02-12

Symptoms: Axillary pain and swelling, now improving

Release 11 — 6 months, dose 3

2022-05-01

Symptoms: Covid symptoms-see below

Release 11 — day 7, dose 4

2022-05-19

Systemic reaction (other): Very heavy menses

Release 11 — day 21, dose 4

2022-06-04

Symptoms: Endometrial intraepithelial neoplasm
Healthcare visit (other): Will have surgery

Release 12 — day 42, dose 4

2022-06-25

Symptoms: Surgery for precancerous/early cancer endometrium
Healthcare visit (other): Surgery 6/24

Release 12 — day 14, dose 5

2022-10-01

Symptoms: Low grade temp and severe fatigue 2 days with negative Covid test x2, now resolved; did begin 3 days after an exposure

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSurgery · · ✓
HCVOUnevaluable event · · ✓
SDAxillary pain ✓ ✓ ✓
SDBody temperature increased · · ✓
SDEndometrial cancer stage 0 · · ✓
SDEndometrial hyperplasia · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDFatigue · · ✓
SDLymphadenopathy ✓ ✓ ✓
SDMalaise · · ✓
SDSARS-CoV-2 test negative · · ✓
SDTumour excision · · ✓
SROAxillary pain ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROHeavy menstrual bleeding · · ✓
SROMigraine ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROUnevaluable event ○ ○ ○

✓ active code · ○ coded but marked inactive · blank = not in that release